Abstract
It has been suggested that COVID-19 patients have distinct tongue features, which may help to monitor the development of their condition. To determine if there was any specific tongue coating feature in COVID-19, this study investigated the difference in tongue coating between COVID-19 subjects and subjects with other acute inflammatory diseases characterized by fever. Tongue images taken with smartphones from three age-matched groups, namely, COVID group (n=92), non-COVID febrile group (n=92), and normal control group (n=92), were analyzed by two blinded raters according to a tongue coating scoring scheme, which assessed the levels of thick fur, slimy or greasy fur, discolored fur and composite index of tongue coating. Compared with control, significant increases in all coating indexes were found in the COVID group (P<0.001), as well as in the non-COVID febrile group (P<0.001). However, no difference was observed between COVID and non-COVID febrile groups for all coating indexes measured. In COVID-19 subjects, their scores of coating indexes had weak but significant correlations with certain inflammatory biomarkers, including WBC and neutrophil - lymphocyte ratio. It is concluded that COVID-19 subjects have pathological tongue coating patterns that are associated with inflammatory responses, and these coating patterns can help to indicate the direction of disease development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has been supported by funds from HKBU Faculty Research Grant (FRG2/17-18/095), a donation grant to HKBU by Ms Flora Chan (NWSI-15-16-01, CMTR), Emergency Special Funding Project of the State Administration of Traditional Chinese Medicine (No. 2020ZYLCYJ05-12), and the Special Funding Project of Guangdong Provincial Department of Education for the Prevention and Control of COVID-19 in Universities (No. 2020KZDZX1053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee of Hong Kong Baptist University (REC/19-20/0400), Ethics Committee of The Third Affiliated Hospital of Guangzhou University of Chinese Medicine (AF/SC- 07/02.0) and Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (AF/04-06.1/10.0).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
2 authors deleted(Luqi Huang,Wenliang Lv) from author list Compliance with ethics guidelines(2 names deleted(Luqi Huang,Wenliang Lv))
Data Availability
Data cannot be shared publicly because of patient privacy. Data are available from corresponding author in Hong Kong Baptist University for researchers who meet the criteria for access to confidential data.
